Illumina plunged 20% after the genetic-sequencing company lowered annual revenue growth estimate. The company also increased its reserve for legal expenses.
ILMN
ILMN
If you want to see the full data, please log in to your account. Logging in gives you complete access to all available information, features, and detailed insights that are not visible to guest users.